Neuraxial block may be associated with a high risk for postoperative cardiac complications .
This report has been verified
by one or more authors of the
original publication.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Neuraxial block, death and serious cardiovascular morbidity in the POISE trial
Br J Anaesth. 2013 Sep;111(3):382-90. doi: 10.1093/bja/aet120. Epub 2013 Apr 23.7925 patients from the POISE trial were included in this post-hoc analysis regarding neuraxial block. The purpose of this analysis was to determine whether neuraxial block was significantly associated with the primary composite outcome (i.e., cardiovascular death, non-fatal myocardial infarction, or non-fatal cardiac arrest), myocardial infarction, stroke, and clinically-significant hypotension over 30 days post-operation. Results indicated that neuraxial block was associated with an increased risk for the primary composite outcome and myocardial infarction, but not stroke or death. There was a non-significant trend towards neuraxial block being associated with clinically-significant hypotension, and the administration of beta-blockers did not influence these results.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
